Spesana

Optimism is emerging in healthcare business discussions. While we survived the post-COVID struggles of healthcare inefficiencies and upside-down incentives and economics, there is now a fresh sense of openness to NEW ideas; specifically platforms replacing point-to-point solutions in healthcare systems & community practices. The power of Spesana lies in its visionary approach and transformative impact across the entire healthcare ecosystem. We’re not just innovating—we’re reshaping healthcare by seamlessly integrating new science, real-world data, and cutting-edge software. Our platform uniquely amplifies the existing healthcare technology infrastructure for physicians, diagnostic labs, pharma, and payers, driving behavioral change without requiring costly overhauls. By enhancing what's already in place, Spesana creates a networked, efficient system that improves patient outcomes and operational efficiency for all stakeholders. Partners across clinical sites, pharma, labs, payers are beginning to understand the power of a collaborative approach of a platform that benefits many constituents. Exciting times and thanks to all the innovators making a difference! #healthtech #precisionmedicine #ihatecancer #clinicaltrials

Powerful words from our Founder & CEO, Carla Balch.

Let me be clear...Spesana is not a revenue cycle company. Our solutions are purpose built to enhance patients' lives across the care continuum. Spesana Authorize is intentionally designed to eliminate the functional burden of manual processes and expedite the speed of authorization, resulting in faster time to diagnosis and faster time to treatment. Spesana Authorize is a patient centric enablement solution. Our mission is clear, patients can no longer wait for healthcare administrators to break free from the inertia of the status quo... American Society for Radiation Oncology (ASTRO) has highlighted a study that links each week of delay in starting cancer therapy with a 1.2% - 3.2% increased risk of cancer death. American Society for Radiation Oncology (ASTRO) estimate that prior authorization costs radiation oncology clinics $40 million a year. American Society for Radiation Oncology (ASTRO) has stated that 93% of radiation oncologists said their patients’ lifesaving treatments are delayed due to prior authorization. 31% said the average delay lasts longer than five days — an entire week of standard radiation treatments. Every week I see articles highlighting the billions of dollars being poured into AI technologies and novel therapeutic pathways. None of these can ever be fully realized if the delays in the prior authorization process continue. Spesana is the catalyst to break free from the archaic manual prior authorization processes that continue to plague our healthcare system. The indifference of healthcare administrators and the adversity to change is something that patients can no longer afford in their "fight of all fights!" https://lnkd.in/gGswjmvu. #radiationoncolgy #improvepatientcare #fastertimetodiagnosis #precisionmedicine #fastertimetotreatment #priorauthorization #moleculardiagnostics #asco #astro #usonoclogy #aon #cornerstone

Spesana is revolutionizing the prior authorization process in Physical Therapy practices by reducing time to treatment and eliminating manual submission tasks. The 90% decrease in PA Cycle Time and 70% decrease in PA Manual Tasks is optimizing work streams in practices and ultimately improving patient care. Spesana Authorize Delivers Value-Based Improvements : - Instant PA Determinations - Real Time Payer Specific Payer Submission Requirements - Rapid Insurance Investigation & EBVs - Highly Efficient Attachment of Patient Medical Records - Customizable ePA Performance Metrics Spesana is actively solving for the immediate needs that are not only well-defined, but acknowledged by clinicians everyday. Please reach out to learn how Spesana can transform your manual Prior Authorization processes today. Select Medical PRORehab combined with Athletico Physical Therapy PT Solutions Physical Therapy Concentra HealthPRO Heritage BenchMark Physical Therapy CHAMPION PHYSICAL THERAPY AND PERFORMANCE, INC SSM Health Physical Therapy REHABILIATION ASSOCIATES PC Pivot Physical Therapy, an Athletico Company ProMedica NovaCare Rehabilitation FLEXION OCCUPATIONAL & PHYSICAL THERAPY PLLC FYZICAL Therapy & Balance Centers Advanced Physical Therapy #electronicpriorauthorization #enhancedpatientcare #fastertoapproval #fastertimetotreatment #fastertimetopayment #physicaltherapy

Truly insightful article from Healthcare Financial Management Association (HFMA) and Jonathan Wiik MHA MBA FHFMA at FinThrive. The negative impact to patient care driven by delays in archaic prior authorization processes continue stall time to diagnosis, treatment, and even clinical trial identification & enrollment. Spesana, led by Carla Balch, continues to solve for the challenges, highlighted in this well-substantiated article, with innovative solutions that reach far beyond electronic prior authorizations. The harmonization of clinical data & work streams is dismantling the silos that continue to plague healthcare. The challenges are real and our team values organizations like FinThrive & Healthcare Financial Management Association (HFMA) that are elevating awareness and the statistics. - 70% of respondents say improving the prior authorization process is a key initiative in 2024, and 41% plan to invest in an electronic prior authorization solution. - 82% say improving the prior authorization process is a top strategy to improve payer-provider collaboration. https://lnkd.in/d9ThfkqN Spesana is actively solving for these challenges and are looking for partners in this effort to solve for the "Gaps in Precision Medicine" & Prior Authorization . Hemant Goel Cheryl Alden Evan Goad, CFA Mark Janiszewski John Landy Brad Rennick John Yount C. Ann Jordan, J.D. Daniel Posey Atif Albraiki Todd Nelson Joseph Favata, CRCR @Nicole Weaver #electronicpriorauthorization #precisionmedicine #cmsruling #oncology #clinicaltrials #healthcarefinance #payers #eliminatedenials #fastertimetotreatment #fastertimetodiagnosis #healthequity

Spesana is actively solving for the greatest challenges in Molecular & Genetic Testing laboratories today: - Electronic Test Ordering : Ensures complete TRFs and reduces ordering errors that delay diagnosis, treatment, & identification of clinical trials. - Electronic Prior Authorization : Ensures that payer requirements are updated in real-time to accelerate submission and increase 1st time rates of approval. - Electronic Medical Record Integration : Ensures that required information for prior authorization is rapidly available through seamless harmonization. "Prior authorization typically requires that a provider submit information to the payor detailing why a particular service is medically necessary and why the patient is eligible to receive it. It can be an administratively complicated process due to the fact that different payors may want different information submitted using different paperwork." - 360Dx Rapid deployment of Spesana solves for all three of these challenges simultaneously and ultimately enhances cancer patient care and outcomes. Clinical Laboratory Management Association - CLMA The Dark Intelligence Group College of American Pathologists (CAP) Association for Molecular Pathology (AMP) American Society of Clinical Oncology (ASCO) Clinical Lab 2.0 https://lnkd.in/gFKWJzjv. #electronicpriorauthorization #electronictestordering #emrintegration #moleculardiagnostics #ngs #precisionmedicine #oncology #clinicaltrials #therapymatching #genetictesting #somatic #germline #dna #rna #liquidbiopsy #multiomics

For some time, I have contemplated why healthcare is so adverse to change.  Especially when the known result is improved patient outcomes through the enhancement of workstreams and actionable information.  I would contend that the greatest obstacle to change is not simply competing technologies or solutions, but the “Inertia of the Status Quo”. Inertia…a tendency to do nothing or to remain unchanged.  The inherent property of a body that makes it oppose any force that would cause a change in its motion.  The lack of activity or interest, or unwillingness to make an effort to do anything. Healthcare systems and supporting functions are plagued by organizational inertia.  The inability to change direction simply because of the momentum that already exists is not a reason to limit innovation. Spesana is a disease state agnostic solution that harmonizes actionable information and optimizes workstreams.  Our team is fighting the “Inertia of the Status Quo” every day. Colorado Flat Tops Wilderness 10,850 ft - Giant stones were moved across mountains...unable to resist the force of change. Spesana continues to partner with organizations working to move "giant stones" against the "Inertia of the Status Quo" in healthcare. #fightinertia #precisionmedicine #oncology #moleculardiagnostics #healthcarechange #ai #ngs #movingboulders #fightthestatusquo

Spesana Founder/CEO Carla Balch Joins the League of Super Business Women By Greg Akers – Editor-in-Chief, Memphis Business Journal Aug 2, 2024 Every year, MBJ honors the top female leaders in the Memphis area with the Super Women in Business event. This marks the 12th Super Women in Business. And it is indisputably one of the top events MBJ produces, year in and year out. Ask anyone who has ever attended. It cannot be missed. Each year has its own flavor, driven by the personalities of the individual women being honored. But over time, one also sees the universality of what makes each of them so successful and worthy of being honored: their intellect, vision, resolve, bravery, creativity, empathy, passion, compassion, energy, and persistence — and, no less, a je ne sais quoi that beguiles attempts to delimit who they are. The celebration event will include all 25 Super Women September 26th at #MemphisBotanicGardens.

The patient always comes first in every decision and partnership we form. Spesana is thrilled to be expanding our precision medicine solution through our new collaboration with IMIDEX, and Wes Bolsen, CEO & Richard Vlasimsky, CTO. The ability to harmonize both Radiographic AI driven detection of lung nodule and mass detection with molecular diagnostics will only further enhance the ability of healthcare providers to identify and treat patients with lung cancer. "Imagine a world where lung cancer is detected early, treatment begins sooner, and patients have a fighting chance for a better prognosis," Spesana CEO - Carla Balch. https://lnkd.in/gg5CCemJ

American Medical Association has made a clear and compelling case that the current Prior Authorization Processes are broken. Spesana Authorize is proving that electronic prior authorization is not only eliminating the archaic manual paradigms but is improving time to approval, time to diagnosis, time to treatment, and time to payment. It is clear that there is a definable problem and the question remains, "Is your organization bold enough to embrace the change necessary?" Reach out to learn more about our no-risk trial. https://lnkd.in/g6PtU_hN Patients and Physicians Speak Out :" See how patients and health care professionals around the country are negatively impacted by prior authorization burdens. https://lnkd.in/g4NjNnuv